췌장암 치료 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPMD00002009
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 133
Buy Now

[연구보고서]췌장암치료제 시장은 2017년 20억1120만달러에서 2025년 40억5640만달러에 이를 것으로 예상된다. 2018년부터 2025년까지 연평균 성장률(CAGR) 8.1%로 성장할 것으로 추정됩니다. 췌장암은 췌장 세포가 통제할 수 없을 정도로 성장할 때 시작됩니다. 췌장암은 영향을 받은 세포의 유형에 따라 외분비 종양과 내분비 종양의 두 가지 유형으로 분류됩니다. 이 종양은 다르게 행동합니다. 따라서 그들은 다르게 취급됩니다. 췌장암은 증상이 쉽게 발견되거나 진단되지 않기 때문에 일반적으로 후기 단계에서 진단됩니다. 췌장의 만성 염증(췌장염), 당뇨병, 흡연, 비만과 같은 요인이 췌장암의 확인된 원인 중 일부입니다. 췌장암 치료제 시장 성장은 췌장암 환자 수 증가, 췌장 치료제에 대한 의료비 지출 증가, 시장에 출시된 치료제 수 증가 등의 요인에 기인합니다. 또한, 췌장암 치료를 위한 효율적인 치료법의 개발은 예측 기간 동안 시장을 자극할 것으로 예상됩니다. 그러나 치료법의 부작용과 낮은 치료 성공률로 인해 췌장암 치료법 시장은 위축될 것으로 예상됩니다.



췌장암 치료법의 수익성이 좋은 지역 시장



시장 통찰력

췌장암 환자 증가



췌장암은 췌장 조직에서 발생하여 주변 장기로 빠르게 퍼지는 공격적인 암 중 하나입니다. 췌장암은 세계에서 12번째로 흔히 발생하는 암입니다. 미국 암학회(American Cancer Society)에 따르면, 2018년에는 미국에서 약 55,440명의 환자가 췌장암 진단을 받을 것으로 예상됩니다. 또한 ACS에서는 췌장암이 미국에서 암과 관련된 사망 원인 3위를 차지하고 있으며 향후에도 췌장암이 발생할 것으로 예상하고 있습니다. Cancer Research UK에 따르면, 2015년 영국에서 약 9,921명의 새로운 췌장암 사례가 진단되었으며, 8,912명의 환자가 동일한 암으로 사망했습니다. 암은 거의 항상 치명적이므로 환자에게 잠재적인 치료법이 필요합니다. 치료. 예를 들어, 미국 암학회(American Cancer Society)에서는 췌장암이 미국 전체 암 사망의 약 3%를 차지한다고 제안합니다. 국립보건원(National Institute of Health)에 따르면, 2015년 기준 미국 내 췌장암 환자 수는 68,615명으로 추산됩니다. 췌장암의 발생률과 유병률이 증가함에 따라 환자의 약물, 치료법 및 치료에 대한 수요도 증가할 것으로 예상됩니다. 더욱이, 환자 수가 증가함에 따라 분자 생물학 및 화학 약물 제제의 발전이 이루어졌습니다. 따라서, 막대한 양의 췌장암 환자 풀이 예측 기간 동안 전 세계 췌장암 치료 시장의 성장을 증가시킬 것으로 예상됩니다.



유형 통찰력



유형에 따라, 췌장암 치료제 시장은 내분비성 췌장암과 외분비성 췌장암으로 구분된다. 2017년에는 외분비성 췌장암 부문이 유형별로 시장 점유율 1위를 차지했습니다. 외분비 췌장암 부문은 이러한 유형의 암이 가장 흔하고 주로 발생하는 유형이므로 예측 기간 동안 대규모 환자 풀을 보유할 것으로 예상되므로 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.



유형별 글로벌 췌장암 치료 시장(2017년 및 2025년)



치료 통찰력



치료를 기준으로 췌장암 치료 시장은 생물학적 치료, 화학 요법 등으로 분류됩니다. 2017년에는 생물학적 치료 부문이 치료법별로 시장에서 가장 큰 점유율을 차지했습니다. 더욱이, 생물학적 치료 부문은 새로운 면역치료제의 증가와 심각한 부작용 없이 암을 치료하고 기존 치료법에 비해 많은 치료 이점을 갖는 표적 세포 치료법의 증가로 인해 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예상됩니다. 화학요법.



전략적 통찰



유기농 전략은 췌장암 치료 시장의 기업이 더 일반적으로 채택하는 전략으로, 이를 통해 글로벌 입지와 제품 및 서비스 포트폴리오를 확장할 수 있습니다. 또한 시장 참여자들은 제품 승인, 임상 시험 및 기타 전략과 같은 유기적 전략을 채택하여 글로벌 고객 기반을 확대하고 브랜드 이름을 전 세계적으로 유지할 수 있게 되었습니다.



글로벌 췌장암 치료 시장 - 유형별





  • 외분비 췌장암

  • 내분비 췌장암


글로벌 췌장암 치료 시장 - 치료법별





  • 생물학적 치료

  • 화학요법

  • 기타


세계 췌장암 치료 시장- 지역별





  • 북미

    • 미국

    • 캐나다

    • 멕시코



  • 유럽

    • 프랑스

    • 독일

    • 이탈리아

    • 영국

    • 스페인



  • 아시아 태평양 (APAC)

    • 중국

    • 인도

    • 대한민국

    • 일본

    • 호주


  • 중동 및 아프리카(MEA)

    • 남아프리카공화국

    • 사우디아라비아

    • UAE



li>
  • 중남미

    • 브라질

    • 아르헨티나






  • 회사 프로필





    • Eli Lilly 및 회사

    • F. Hoffmann-La Roche Ltd

    • Amgen Inc

    • Novartis AG

    • Celgene Corporation

    • Merck & Co., Inc

    • < li>Pharmacyte Biotech Inc
    • Clovis Oncology

    • Teva Pharmaceutical Industries Ltd

    • Pfizer Inc

    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. Eli Lilly and Company
    2. F. Hoffmann-La Roche AG
    3. Celgene Corporation
    4. Amgen Inc.
    5. Novartis AG
    6. Pharmacyte Biotech Inc.
    7. Clovis Oncology
    8. Teva Pharmaceutical Industries Ltd.
    9. Pfizer Inc.
    10. Merck & Co., Inc.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports